Although sorbistin has a unique chemical structure and broad antibacterial spectrum, its intrinsic activity is not potent enough to be developed for clinical use. In an effort to discover new types of aminoglycoside antibiotics, we attempted to obtain a sorbistin-hypersensitive mutant which might have specific sensitivity to certain groups of aminoglycoside antibiotics.
It is also anticipated that such mutant would be useful in detecting minor aminoglycoside-type components produced in fermentation broth. Based on this concept, Klebsiella pneumoniae type No. 22 (Kp-8), which is a clinical isolate highly resistant to various kinds of antibiotics, was used as the parent strain for mutation studies. A sorbistin-sensitive strain, Kp-126, was isolated from Kp-8 after a series of treatments with N-methyl-N'-nitro-N-nitrosoguanidine (NTG) and following selection by the replica plate method. The mutant also showed sensitivity to a wide range of number of the aminocyclitol group of aminoglycoside antibiotics.
The present paper deals with the isolation and characterization of the aminoglycoside hypersensitive mutant Kp-126, and some results of its use in our antibiotic screening. 
Media
Heart infusion broth (HIB), Heart infusion agar (HIA) and Mueller-Hinton agar (MHA) were purchased from Difco Laboratories Incorp.7). Nutrient broth agar (NBA) containing meat extract 0.5 %, peptone 1 %, NaCI 0.5 % and agar (Eiken) 1.5 % was also used. The pH of these media was adjusted to 7.0' 7.2 by NaOH before autoclaving.
Characterization of Strains
Physiological and biochemical properties of the strains were examined according to the literature8) and also by using a diagnostic kit (Enterotube II, Roche) for identification of Enterobacteriaceae.
Determination of Virulence Virulence of the mutant and parent strains was tested in male, albino, ICR-SPF mice weighing 18 20 g. Groups of 10 mice were used for six levels of bacterial challenge. Mice were challenged intravenously with 0.2 ml bacterial suspension (104' 1010 cells/ml) in physiological saline. The cells were obtained after incubation in HIB for 18 hours at 32°C and the number of viable cells in the saline suspension was determined on NBA plates. The bacterial virulence was assessed by the LD50 (cells/ mouse) determined 4 days after the challenge.
Determination of Minimum Inhibitory Concentration (MIC)
The MICs of various antibiotics against the mutant and parent strains were determined by the two-fold dilution method on MHA or HIA plates using a Steer's multi-inoculating apparatus. Inoculum was standardized to be a 10-4 dilution of bacterial suspention (OD=0.45 at 540 nm) which was prepared from overnight culture in HIB medium.
Paper Disc Assay for Antibiotic Sensitivity Test strains were incubated in HIB medium at 28°C overnight on a rotary shaker. Each 10-m1 molten agar medium (NBA adjusted pH to 9.0) containing 1 % inoculum of the test organism was poured into a plastic plate (8.8 cm in diameter). After the agar medium solidified at room temperature, paper discs (8 mm in diameter) containing 35 pl of graded amounts of antibiotics were placed on the agar plates and the plates were incubated at 28°C for 20 hours.
Screening of Antibiotics Active against Kp-126
Strains isolated from soil were cultured in a variety of media with rotary shaking (180 rpm) for 4 days at 28°C. Harvested broths were centrifuged and the supernatants were used for screening. Antibiotic activity against Kp-126 was assayed by the paper disc agar diffusion method.
Results

Isolation of Mutant
Mutation studies using the highly resistant strain Kp-8 were carried out by the procedure as shown in Fig. 1 . Kp-8 cells treated with NTG were spread on NBA plates. The plates incubated at 37°C for 2 to 4 days were replicated to the NBA plates containing graded concentrations of sorbistin below the MIC for the parental strain. The colonies which did not grow on the sorbistin-containing plates were picked up and cloned by streaking onto non-medicated NBA plates. After determining the MIC of sorbistin A1 against the mutants, the most sensitive strain at each step was used as the parent strain for the next step. This selection procedure was repeated 3 times. Among 13 mutants which were inhibited by 3.1 pg/ml of sorbistin A1, a strain, No. 116, was selected because of its broad sensitivity to various aminoglycoside antibiotics.
The mutant No. 116 was treated with chloramphenicol to induce the resistance to non-amino-glycoside antibiotics. After incubation for 2 to 7 days in HIB medium containing graded concentration of chloramphenicol, a full growth culture was transferred into a fresh medium with increasing amounts of the drug. This procedure was repeated three times to obtain strains resistant to 25 ,ug/ml of chloramphenicol. Among the resistant strains cloned, Kp-126 was finally selected for the present study. 
Properties of Mutant Strain Kp-126
The parent strain Kp-8 formed slightly mucoid colonies on the agar medium and possessed prop-VOL. XXXIX NO. 7 THE JOURNAL OF ANTIBIOTICS erties typical of Klebsiella; indole and methyl red negative, Voges-Proskauer and citrate positive, nonmotile. In addition, this strain was positive for urease, (3-galactosidase and lysine decarboxylase, did not produce hydrogen sulfide, and lacked phenylalanine deaminase and ornitine decarboxylase9).
The physiological and biochemical characteristics of Kp-126 were almost the same as those of the parent strain excepting quantitative differences observed in the formation of gas, acid and acetoin from glucose, and urease activity ( Table 1 ).
The virulence of the mutant to mice (LD50=3.0 x 108 cells/mouse) was several times weaker than that of the parent strain (LD50=8.9 x 107 cells/mouse). However, Kp-126 was less sensitive than Kp-1 and Ec-1 to chloramphenicol, aureothricin and colistin. 
Discussion
Antibiotics BMY-28251, discovered through the previously described screen, was specifically active against Kp-126, and was identified as 3,3'-diamino-3,3'-dideoxy-a,(3-trehalose13).
BMY-28251 was also discovered in the fermentation broth of butirosin-producing organism as a previously undetected component in the course of another application of Kp-126 related to studies of butirosin biosynthesis14).
Mutants of Pseudomonas aeruginosa, which showed specific hypersensitivity to aminoglycosides, were genetically studied by MILLS and HOLLOWAY" in connection with the alteration of susceptibility to aeruginosin. A similar Pseudomonas mutant was also obtained from the highly resistant strain of P. aeruginosa, Pa-50, in our laboratory, but its sensitivity to aminoglycoside antibiotics was insufficient to be used for the routine screening.
Our mutant strain Kp-126 is the first example of a Klebsiella strain hypersensitive to aminoglycoside antibiotics. Its use in screening is expected to result in the discovery of new aminoglycoside antibiotics.
